Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03523273 · ClinicalTrials.gov registry record · Phase 2

Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity

A Phase 2 study of Obesity, sponsored by Michael Camilleri, MD.

Completed
Registry status
Phase 2
Development phase
136
Enrollment target
1
Study location

NCT03523273: Completed Phase 2 study of Obesity, sponsored by Michael Camilleri, MD.

NCT03523273 is a Phase 2 study of Obesity that has completed, run by Michael Camilleri, MD. The registered enrollment target is 136 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03523273, a Phase 2 study of Obesity, has completed, sponsored by Michael Camilleri, MD.

COMPLETED
Registry status
Phase 2
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

This study is being done to assess the stomach emptying effect of a maximum dose of 3 mg Liraglutide compared to placebo in subjects who are overweight or obese. Liraglutide is a medication approved by the Food and Drug Administration (FDA) for routine clinical use.

Conditions Studied

Obesity

Interventions

  • DRUG Placebo
  • DRUG Liraglutide

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2017-11-29
Est. Completion 2021-08-31
Phase Phase 2

Sponsor

Michael Camilleri, MD

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03523273

The ClinicalTrials.gov registry entry for NCT03523273 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower). The listed sponsor is Michael Camilleri, MD, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03523273 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03523273 about?

NCT03523273 is a clinical study titled "Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity". This study is being done to assess the stomach emptying effect of a maximum dose of 3 mg Liraglutide compared to placebo in subjects who are overweight or obese. Liraglutide is a medication approved by the Food and Drug Administration (FDA) for routine clinical use.

What is the current status of trial NCT03523273?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 136 participants. The study started on 2017-11-29. Estimated completion is 2021-08-31.

What conditions does trial NCT03523273 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03523273?

The interventions under investigation include: Placebo (DRUG), Liraglutide (DRUG).

Who is sponsoring clinical trial NCT03523273?

This trial is sponsored by Michael Camilleri, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03523273 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.